Health Care/Hospital
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
SINGAPORE, March 12, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River Laboratories ("Charles River"), a global contract research organization (CRO) providing drug dev...
Sky Labs Launches their support of the American Heart Association's 'Established Investigator Award for Clinical Hypertension'
SEOUL, South Korea, March 12, 2026 /PRNewswire/ -- Sky Labs announced on 12th that it is supporting the Established Investigator Award for Clinical Hypertension' developed by the American Heart Association (the Association). This support follows a Memorandum of Understanding (MoU) signed with t...
LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility
WUXI, China, March 12, 2026 /PRNewswire/ -- LabConnect, a leading provider of
technology-drivencentral laboratory services
Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the leading br...
IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent
ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc
DermRays Launches Lumenic™ Dual-Light & 3D-Oscillo™ System for At-Home Professional Teeth Whitening
NEW YORK, March 11, 2026 /PRNewswire/ -- DermRays
Ulike Announces Official Partnership with the PCOS Awareness Association (PCOSAA)
NEW YORK, March 11, 2026 /PRNewswire/ -- Millions of women worldwide live with Polycystic Ovary Syndrome (PCOS), a complex hormonal condition that remains widely underdiagnosed, stigmatized, and misunderstood. Beyond its medical implications, PCOS often affects mental health, self-esteem, and dai...
HelpMeSee Featured in "Healthier Together," Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training
NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit
organization dedicated to eliminating preventable cataract blindness, is
featured in Healthier Together
Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 25, 2026
BEIJING, March 11, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, 'MAV/06'
* Demonstrates effectiveness comparable to the global standard Oka strain vaccine YONGIN, South Korea, March 11, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that a review paper comprehensively analyzing the safety...
Haier Biomedical Hosts European Partner Summit in Rome and Advances "In Europe, for Europe" Strategy
ROME, March 11, 2026 /PRNewswire/ -- Haier Biomedical
Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer
SUZHOU, China, March 11, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the appointment of Dr. Hongwei Wang as Chief Technology Officer (CTO). Dr. Wang will be responsible for the company's Process Development and Analytical Development Department, Production Department an...
MindHYVE.ai™ and California Northstate University Deploy First Agentic AI Learning Platform in U.S. Health Sciences Education
CNU becomes the first U.S. health sciences university to integrate a reasoning-first adaptive AI system into its College of Pharmacy curriculum NEWPORT BEACH, Calif. and ELK GROVE, Calif., March 11, 2026 /PRNewswire/ -- MindHYVE.ai™, Inc. and California Northstate University (CNU) have signed a ...
Kipu Health Announces Frankie Russo and Adam David as Headliners for Elevate 2026
Executive programming, industry sponsors, and the inaugural Kipu Cup golf tournamentround out a premier gathering of behavioral health leaders MIAMI, March 10, 2026 /PRNewswire/ -- Kipu Health today announced that bestselling author and culture strategist Frankie Russo and acclaimed performer an...
Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements
BEIJING, March 10, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd. ("
Tsingke Biotech
Registrational Phase III AMPLIFY trial: Target number of participants achieved
SYDNEY, March 10, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Phase III A...
Zepp Health Corporation to Report Fourth Quarter and Full Year 2025 Financial Results on March 15, 2026
Earnings Call Scheduled for 9:30 p.m. ET on March 15, 2026 MILPITAS, Calif., March 10, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its fourth quarter and ...
Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026
SHANGHAI, March 10, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its financial re...
Ascletis Announces Positive Topline Results from U.S. Phase II, 24-Week Study for Its Ultra-Long-Acting Subcutaneous Depot Formulations of Small Molecule GLP-1R Agonist ASC30 for Obesity
- ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after three monthly doses. - ASC30 SQ depot formulation maintained weight loss for the four months following the third and final mon...
Banyan Tree Deepens Wellbeing Experiences with Expansion of its Signature Connections Programme, New Retreats, Visiting Practitioners and Global Partnership with Manduka
SINGAPORE, March 10, 2026 /PRNewswire/ -- Banyan Tree,
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00